Hepatoprotective effects of the xanthine oxidase inhibitor Febuxostat against thioacetamide-induced liver injury in rats: The role of the Nrf2/HO-1 and TLR4/NF-κB …
RS Abdelrahman, ME Abdelmageed - Food and Chemical Toxicology, 2024 - Elsevier
Experimental models of liver injury have been established utilizing thioacetamide (TAA), a
classic liver toxic chemical that causes organ damage via oxidative stress and inflammatory …
classic liver toxic chemical that causes organ damage via oxidative stress and inflammatory …
CXCL8 promotes endothelial-to-mesenchymal transition of endothelial cells and protects cells from erastin-induced ferroptosis via CXCR2-mediated activation of the …
H Ji, L Chen, M Ren, S Li, T Liu, H Chen, H Yu, Y Sun - Pharmaceuticals, 2023 - mdpi.com
CXCL8-CXCR1/CXCR2 signaling pathways might form complex crosstalk among different
cell types within the ovarian tumor microenvironment, thereby modulating the behaviors of …
cell types within the ovarian tumor microenvironment, thereby modulating the behaviors of …
Lactoferrin averts neurological and behavioral impairments of thioacetamide-induced hepatic encephalopathy in rats via modulating HGMB1/TLR-4/MyD88/Nrf2 …
RM Essam, MA Saadawy, M Gamal, RM Abdelsalam… - …, 2023 - Elsevier
Hepatic encephalopathy (HE) is a life-threatening disease caused by acute or chronic liver
failure manifested by aberrant CNS changes. In the present study, we aimed to explore the …
failure manifested by aberrant CNS changes. In the present study, we aimed to explore the …
The Mechanism of Hepatic Encephalopathy Induced by Thioacetamide Based on Metabolomics and Proteomics: A Preliminary Study
H Guo, G Wang, W Huang, L Li, Y Bai, H Wang… - International Journal of …, 2023 - mdpi.com
Hepatic encephalopathy (HE) is a central nervous system dysfunction syndrome caused by
acute and chronic liver failure or various portal systemic shunt disorders. HE arises from …
acute and chronic liver failure or various portal systemic shunt disorders. HE arises from …
Naringenin mitigates thioacetamide-induced hepatic encephalopathy in rats: Targeting the JNK/Bax/caspase-8 apoptotic pathway
Hepatic encephalopathy (HE) is a serious neurological disorder which is related to liver
dysfunction. HE was induced by thioacetamide (TAA) injection (350 mg kg− 1, ip) for 3 …
dysfunction. HE was induced by thioacetamide (TAA) injection (350 mg kg− 1, ip) for 3 …
Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
Recent interest in mushrooms and their components as potential therapies for mental health,
along with recent government and health authority approvals, has necessitated a more …
along with recent government and health authority approvals, has necessitated a more …
Cinnamaldehyde/lactulose combination therapy alleviates thioacetamide-induced hepatic encephalopathy via targeting P2X7R-mediated NLRP3 inflammasome …
G Al Shaima, NA Abd Elrazik - Life Sciences, 2024 - Elsevier
Aims Cinnamaldehyde (CA), the main active constituent of cinnamon oil, is reported to have
neuroprotective effects. However, the potential benefits of CA for brain protection in hepatic …
neuroprotective effects. However, the potential benefits of CA for brain protection in hepatic …
Association between proton pump inhibitors and risk of hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt: a protocol for a …
Y Su, Y Chen, J Zheng, C Yao - BMJ open, 2024 - bmjopen.bmj.com
Introduction Hepatic encephalopathy (HE) is a major complication of acute liver failure,
cirrhosis and transjugular intrahepatic portosystemic shunt (TIPS) placement. Its clinical …
cirrhosis and transjugular intrahepatic portosystemic shunt (TIPS) placement. Its clinical …
[HTML][HTML] Protocol: Association between proton pump inhibitors and risk of hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt …
Y Su, Y Chen, J Zheng, C Yao - BMJ Open, 2024 - ncbi.nlm.nih.gov
Introduction Hepatic encephalopathy (HE) is a major complication of acute liver failure,
cirrhosis and transjugular intrahepatic portosystemic shunt (TIPS) placement. Its clinical …
cirrhosis and transjugular intrahepatic portosystemic shunt (TIPS) placement. Its clinical …
Targeting angiogenic and proliferative mediators by montelukast & trimetazidine Ameliorates thioacetamide-induced liver fibrosis in rats
RS Abdelrahman, AA Elnfarawy, AE Nashy… - Toxicology and Applied …, 2024 - Elsevier
Liver fibrosis is a significant health complication with the potential to result in serious
mortality and morbidity. However, there is no standard treatment due to its complex …
mortality and morbidity. However, there is no standard treatment due to its complex …